Michael Yee
Stock Analyst at Jefferies
(3.17)
# 1,205
Out of 5,111 analysts
78
Total ratings
45.28%
Success rate
15.28%
Average return
Main Sectors:
Stocks Rated by Michael Yee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALXO ALX Oncology Holdings | Upgrades: Buy | $2 → $3 | $1.40 | +114.29% | 5 | Mar 6, 2025 | |
| KOD Kodiak Sciences | Upgrades: Buy | $20 | $23.02 | -13.12% | 3 | Dec 9, 2024 | |
| BIIB Biogen | Downgrades: Hold | $250 → $180 | $175.74 | +2.42% | 5 | Dec 9, 2024 | |
| VRTX Vertex Pharmaceuticals | Upgrades: Buy | $500 → $550 | $455.71 | +20.69% | 4 | Dec 9, 2024 | |
| AMGN Amgen | Maintains: Buy | $380 | $325.31 | +16.81% | 5 | Nov 12, 2024 | |
| DNLI Denali Therapeutics | Maintains: Buy | $40 → $45 | $17.34 | +159.52% | 2 | Nov 1, 2024 | |
| MRNA Moderna | Maintains: Hold | $65 → $55 | $29.92 | +83.82% | 8 | Oct 15, 2024 | |
| MBX MBX Biosciences | Initiates: Buy | $35 | $28.38 | +23.33% | 1 | Oct 8, 2024 | |
| ORKA Oruka Therapeutics | Initiates: Buy | $40 | $30.10 | +32.89% | 1 | Sep 13, 2024 | |
| AXON Axon Enterprise | Initiates: Buy | $385 | $551.79 | -30.23% | 4 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $1.4 → $10 | $8.51 | +17.51% | 3 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $16 → $3 | $5.78 | -48.10% | 2 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $75 → $30 | $26.83 | +11.82% | 2 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $60 → $20 | $14.14 | +41.44% | 8 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $8 → $20 | $45.24 | -55.79% | 3 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $63 → $75 | $12.00 | +525.00% | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $8.34 | +259.71% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $65 | $36.02 | +80.46% | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $1,875 → $1,125 | $10.04 | +11,105.18% | 2 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $40 → $30 | $3.78 | +693.65% | 4 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $30 | $9.97 | +200.90% | 3 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $120 | $34.60 | +246.82% | 2 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $70 → $75 | $18.21 | +311.86% | 2 | Oct 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $76.21 | -60.64% | 1 | Sep 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $77 | $22.85 | +236.98% | 2 | Nov 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $119.78 | - | 3 | Jan 26, 2018 |
ALX Oncology Holdings
Mar 6, 2025
Upgrades: Buy
Price Target: $2 → $3
Current: $1.40
Upside: +114.29%
Kodiak Sciences
Dec 9, 2024
Upgrades: Buy
Price Target: $20
Current: $23.02
Upside: -13.12%
Biogen
Dec 9, 2024
Downgrades: Hold
Price Target: $250 → $180
Current: $175.74
Upside: +2.42%
Vertex Pharmaceuticals
Dec 9, 2024
Upgrades: Buy
Price Target: $500 → $550
Current: $455.71
Upside: +20.69%
Amgen
Nov 12, 2024
Maintains: Buy
Price Target: $380
Current: $325.31
Upside: +16.81%
Denali Therapeutics
Nov 1, 2024
Maintains: Buy
Price Target: $40 → $45
Current: $17.34
Upside: +159.52%
Moderna
Oct 15, 2024
Maintains: Hold
Price Target: $65 → $55
Current: $29.92
Upside: +83.82%
MBX Biosciences
Oct 8, 2024
Initiates: Buy
Price Target: $35
Current: $28.38
Upside: +23.33%
Oruka Therapeutics
Sep 13, 2024
Initiates: Buy
Price Target: $40
Current: $30.10
Upside: +32.89%
Axon Enterprise
Jul 17, 2024
Initiates: Buy
Price Target: $385
Current: $551.79
Upside: -30.23%
Mar 27, 2024
Upgrades: Buy
Price Target: $1.4 → $10
Current: $8.51
Upside: +17.51%
Mar 15, 2024
Downgrades: Hold
Price Target: $16 → $3
Current: $5.78
Upside: -48.10%
Dec 8, 2023
Downgrades: Hold
Price Target: $75 → $30
Current: $26.83
Upside: +11.82%
Oct 25, 2023
Downgrades: Hold
Price Target: $60 → $20
Current: $14.14
Upside: +41.44%
Oct 25, 2023
Upgrades: Buy
Price Target: $8 → $20
Current: $45.24
Upside: -55.79%
Jan 6, 2023
Upgrades: Buy
Price Target: $63 → $75
Current: $12.00
Upside: +525.00%
Nov 15, 2021
Initiates: Buy
Price Target: $30
Current: $8.34
Upside: +259.71%
Mar 2, 2021
Initiates: Buy
Price Target: $65
Current: $36.02
Upside: +80.46%
Mar 2, 2021
Downgrades: Hold
Price Target: $1,875 → $1,125
Current: $10.04
Upside: +11,105.18%
Feb 12, 2021
Downgrades: Hold
Price Target: $40 → $30
Current: $3.78
Upside: +693.65%
Feb 12, 2021
Upgrades: Buy
Price Target: $15 → $30
Current: $9.97
Upside: +200.90%
Nov 6, 2020
Downgrades: Hold
Price Target: $120
Current: $34.60
Upside: +246.82%
Oct 12, 2020
Upgrades: Buy
Price Target: $70 → $75
Current: $18.21
Upside: +311.86%
Sep 14, 2020
Initiates: Buy
Price Target: $30
Current: $76.21
Upside: -60.64%
Nov 8, 2018
Assumes: Buy
Price Target: $77
Current: $22.85
Upside: +236.98%
Jan 26, 2018
Upgrades: Buy
Price Target: n/a
Current: $119.78
Upside: -